IL6 and type 2 diabetes mellitus: The underlying mechanism may be related to inflammatory mediators including IL-6, IL-1α, and TNF-α, which not only promote epithelial–mesenchymal transition through activation of the Janus kinase/signal transducer and activator of trans-ions pathway but also increase the risk of type 2 diabetes (24).